AliveCor QT Service vs EchoSolv AS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AliveCor QT Service

by AliveCor

EchoSolv AS

by Echo IQ

AI Verdict

AliveCor QT Service specializes in analyzing ECGs for QT/QTc interval measurements to assess cardiac safety and inform medication prescribing. Conversely, EchoSolv AS focuses on analyzing echocardiogram measurements to identify patients at risk for severe aortic stenosis. While both are AI-powered cardiology tools, they address distinct cardiac conditions and utilize different diagnostic data, making them suitable for different clinical applications.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary concern is monitoring cardiac safety, particularly regarding medication-induced QT prolongation. This tool is ideal for healthcare professionals who need instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs to inform prescribing decisions and manage patients on QT-prolonging drugs.

View AliveCor QT Service →

Choose EchoSolv AS if…

Choose EchoSolv AS if you need an AI-powered clinical decision support platform to efficiently identify patients at high risk for severe aortic stenosis from echocardiogram measurements. This tool is best suited for cardiology practices or hospitals seeking to streamline their echo review process, prioritize studies, and enhance the accuracy of sAS detection within existing workflows.

View EchoSolv AS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AliveCor QT Service	EchoSolv AS
Pricing	Varies by product and service, with subscription options available.	Unknown
Deployment	Mobile app, cloud-based platform, EHR integration.	Cloud-based
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

Tool B emphasizes seamless integration into existing PACS workflows without requiring EMR integration, which can lower the barrier to adoption. Its ultra-fast risk detection (under 3 seconds) also points to a highly efficient and user-friendly experience once deployed.

Clinical Value

EchoSolv AS

Both tools offer significant clinical value in critical cardiology areas and are FDA-cleared. However, Tool B explicitly includes 'guideline check' and 'second reader support' features, in addition to high-accuracy risk identification, providing a more comprehensive clinical decision support capability.

Pricing & Value

Tie

Neither tool provides transparent pricing information in the structured facts or through public web searches. Both require contacting the vendor for pricing details, making it impossible to compare them on this dimension.

Enterprise Readiness

AliveCor QT Service

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA, and cloud deployment. However, Tool A explicitly highlights a comprehensive API for integration with a wider range of enterprise systems, including EHR, SDK, CRM, EDC, and PSP platforms, suggesting a more robust and flexible integration strategy for large-scale deployments.

Innovation

EchoSolv AS

Both leverage AI for critical cardiac analysis. Tool B's innovative approach of using 'measurement-based AI' that specifically avoids LVOT measurements for severe aortic stenosis detection, coupled with its ultra-fast processing, demonstrates a unique and potentially more robust technical solution within its domain.

Support & Docs

Tie

Neither the provided structured facts nor public web searches offer specific details regarding the availability or nature of support channels and documentation for either product. As both are B2B SaMDs, such information is typically part of direct client agreements, making a public comparison impossible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AliveCor QT Service	EchoSolv AS
Name	AliveCor QT Service	EchoSolv AS
Company	AliveCor	Echo IQ
Primary Clinical Focus	Provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.	Analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency.
Input Data for Analysis	ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L)	Echocardiogram measurements (analyzes numerical measurements, not images)
Key Technology	AI and deep neural networks for ECG analysis	AI-powered clinical decision support
Integration Capabilities	Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms.	Designed to fit existing workflows (no EMR integration required, integrates with PACS).

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and EchoSolv AS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions are these tools designed to assess?

AliveCor QT Service is designed to provide instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis.

What type of patient data is required for each tool's analysis?

AliveCor QT Service analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices, such as KardiaMobile 6L. EchoSolv AS analyzes numerical measurements from echocardiograms, not images, to identify severe aortic stenosis probability.

How do these tools integrate with existing clinical workflows and electronic health records?

AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and an API is available for integration with EHR, SDK, CRM, EDC, and PSP platforms. EchoSolv AS is designed to fit existing workflows and integrates with PACS, without requiring EMR integration.

What are the key differences in how each tool utilizes AI?

AliveCor QT Service utilizes AI and deep neural networks for ECG analysis to provide instant QT measurements. EchoSolv AS uses measurement-based AI to analyze numerical measurements from echocardiograms to determine severe aortic stenosis probability.

What kind of clinical insights or outputs do these tools provide?

AliveCor QT Service provides instant QT and QTc interval measurements (Bazett's and Fridericia's formulas). EchoSolv AS provides consistent severe aortic stenosis probability, a guideline check from measurements, and second reader support to help prioritize studies for closer review.

Is there a difference in their intended use or prescription status?

AliveCor QT Service is for prescription (Rx) use only, intended for qualified healthcare professionals. EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform.

What are the unique technological approaches or features of each tool?

AliveCor QT Service provides instant QT measurements as InstantQT and analyzes ECGs from AliveCor 6-Lead devices. EchoSolv AS's AI does not use LVOT measurements and offers ultra-fast risk detection in under 3 seconds.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AliveCor QT Service or EchoSolv AS

Backers

Who funded each tool's parent company.